TP53 and acute myeloid leukemia: Echinomycin treatment has demonstrated therapeutic effect on acute myeloid leukemia cells with TP53 mutation in xenograft mouse models (Wang et al., 2020), but our study has shown, for the first time, that echinomycin is effective for oncogenic RAS in Drosophila, mouse and human cell systems.